Allogene Therapeutics, Inc. (ALLO)
|Year Range||$5.62 - $17.28|
ALLOShare Price Chart
The chart shows the growth of $10,000 invested in Allogene Therapeutics, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,168 for a total return of roughly -68.32%. All prices are adjusted for splits and dividends.
ALLOCompare to other instruments
ALLOReturns in periods
ALLOMonthly Returns Heatmap
Allogene Therapeutics, Inc. doesn't pay dividends
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the Allogene Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Allogene Therapeutics, Inc. is 89.60%, recorded on Dec 27, 2022. The portfolio has not recovered from it yet.
|-89.6%||May 26, 2020||654||Dec 27, 2022||—||—||—|
|-45.29%||Nov 7, 2018||341||Mar 18, 2020||37||May 11, 2020||378|
|-16.54%||Oct 16, 2018||7||Oct 24, 2018||7||Nov 2, 2018||14|
|-7.25%||May 12, 2020||2||May 13, 2020||1||May 14, 2020||3|
|-0.39%||May 19, 2020||1||May 19, 2020||1||May 20, 2020||2|
Current Allogene Therapeutics, Inc. volatility is 95.89%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.